← SynDRA
GLPG0492
SynDRA canonical compound SYN0034161 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | AR |
|---|
| Mechanism of action | androgen receptor modulator |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Glpg-0492
- (-)-GLPG-0492
- DT-200
- G 100192
- GLPG-0492
- G-100192
- Selective androgen receptor modulators, Galapagos
- Selective androgen receptor modulators, ProSkelia
- Selective androgen receptor modulators, ProStrakan
- SARMs (osteoporosis), ProSkelia
- SARMs (osteoporosis), ProStraken
- SARMs (osteoporosis/cachexia), Galapagos
- 8O59X1ACZT
- RefChem:143519
- UNII-8O59X1ACZT
- MFCD25976946
- orb1709599
- SCHEMBL2021011
- GLXC-25631
- EX-A4626
- QYB08592
- AKOS030526325
- CS-3743
- SB18652
- T11410L
- NCGC00485914-01
- DA-63791
- HY-18102
- MS-26466
- NS00073065
- F85107
- BRD-K15893360-001-01-8
- glpg-0492
Look up GLPG0492 in the interactive SynDRA portal →